Risskov, Denmark

Mads Fuglsang Kjolby

USPTO Granted Patents = 3 

Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 11(Granted Patents)


Location History:

  • Arhus, DK (2015)
  • Risskov, DK (2016 - 2019)

Company Filing History:


Years Active: 2015-2019

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mads Fuglsang Kjolby: Innovator in Obesity Treatment

Introduction

Mads Fuglsang Kjolby is a notable inventor based in Risskov, Denmark. He has made significant contributions to the field of obesity treatment through his innovative research and patented inventions. With a total of three patents to his name, Kjolby is recognized for his work in developing agents that target obesity.

Latest Patents

Kjolby's latest patents focus on SorCS1 for the treatment of obesity. The present invention relates to SorCS1-like agents, including SorCS1 itself, nucleic acid molecules encoding the expression of SorCS1 and its fragments, as well as vectors containing said nucleic acid. Additionally, it encompasses cells expressing SorCS1 and its fragments, all aimed at providing effective treatment options for obesity.

Career Highlights

Throughout his career, Mads Fuglsang Kjolby has worked with esteemed institutions such as Aarhus Universitet and H. Lundbeck A/S. His work in these organizations has allowed him to advance his research and contribute to the scientific community significantly.

Collaborations

Kjolby has collaborated with notable colleagues, including Anders Nykjaer and Karen-Marie Pedersen. These partnerships have further enriched his research and innovation efforts in the field of obesity treatment.

Conclusion

Mads Fuglsang Kjolby is a prominent inventor whose work in obesity treatment through SorCS1-like agents showcases his dedication to addressing significant health challenges. His contributions continue to influence the field and offer hope for effective treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…